ArticleOpen life sciences2021

Inhibition of ADAM10 ameliorates doxorubicin-induced cardiac remodeling by suppressing N-cadherin cleavage.

Xiaoou Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.